These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7152135)

  • 1. Subcutaneous peritoneal access device for type I diabetic patients nonresponsive to subcutaneous insulin.
    Schade DS; Eaton RP; Warhol RM; Gregory JA; Doberneck RC
    Diabetes; 1982 May; 31(5 Pt 1):470-3. PubMed ID: 7152135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of diabetes through a subcutaneous peritoneal access device (SPAD) in patients with resistance to subcutaneously injected insulin.
    Dandona P; Fonseca V; Fernando O; Menon RK; Weerakoon J; Kurtz A; Stephen R
    Diabetes Res; 1987 May; 5(1):47-9. PubMed ID: 3304785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: comparison with intravenous and subcutaneous routes.
    Selam JL; Slingeneyer A; Hedon B; Mares P; Beraud JJ; Mirouze J
    Diabetes Care; 1983; 6(2):105-11. PubMed ID: 6406198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin therapy on the peritoneal route: effects on glucose control in experimental insulin dependent diabetes.
    Fischer U; Fritze K; Freyse EJ
    Exp Clin Endocrinol; 1990 Feb; 95(1):11-21. PubMed ID: 2185935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peritoneal absorption of insulin in diabetic man: a potential site for a mechanical insulin delivery system.
    Schade DS; Eaton RP; Spencer W; Goldman R; Corbett WT
    Metabolism; 1979 Mar; 28(3):195-7. PubMed ID: 763154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of type I diabetic with subcutaneous insulin resistance by a totally implantable insulin infusion device ("Infusaid").
    Campbell IW; Kritz H; Najemnik C; Hagmueller G; Irsigler K
    Diabetes Res; 1984 Jul; 1(2):83-8. PubMed ID: 6442226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients.
    Razavi Z; Maher S; Fredmal J
    Endocrine; 2018 Aug; 61(2):267-274. PubMed ID: 29797212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of resistance to subcutaneous insulin with implanted insulin infusion pumps].
    Löchli S; Campbell I; Dorenboos H; Paterson KR; Devlin JG; Hagmüller G; Irsigler K
    Dtsch Med Wochenschr; 1988 Sep; 113(36):1390-3. PubMed ID: 3138098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous intravenous insulin infusion in the management of brittle diabetes: etiologic and therapeutic implications.
    Williams G; Pickup JC; Keen H
    Diabetes Care; 1985; 8(1):21-7. PubMed ID: 3971843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined continuous subcutaneous insulin infusion and multiple subcutaneous injections in type I diabetic patients.
    Schiffrin A; Belmonte M
    Diabetes Care; 1981; 4(6):595-600. PubMed ID: 6751734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of premeal subcutaneous insulin infusion and injection in type I diabetic patients under continuous basal subcutaneous insulin delivery.
    Navascués I; Kerner W; Pfeiffer EF
    Life Support Syst; 1985; 3(3):263-7. PubMed ID: 3900596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatalities Due to Failure of Continuous Subcutaneous Insulin Infusion Devices: A Report of Six Cases.
    Ziegler A; Williams T; Yarid N; Schultz DL; Bundock EA
    J Forensic Sci; 2019 Jan; 64(1):275-280. PubMed ID: 29940703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraindividual comparison of pharmacokinetics of insulin after intravenous, portal, subcutaneous and peritoneal administration.
    Fritze K; Fischer U; Freyse EJ; Besch W
    Exp Clin Endocrinol; 1988 Mar; 92(3):297-306. PubMed ID: 3075553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Access for starting kidney replacement therapy: vascular and peritoneal temporal access in pre-dialysis].
    Rodríguez CR; Bardón Otero E; Vila Paz ML
    Nefrologia; 2008; 28 Suppl 3():105-12. PubMed ID: 19018747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
    Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
    Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with insulin analog lispro in IDDM with delayed absorption of subcutaneously applied human regular insulin and complicated intraperitoneal insulin infusion. A case report.
    Meier M; Brand J; Standl E; Schnell O
    Diabetes Care; 1998 Jul; 21(7):1044-5. PubMed ID: 9653592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperkalaemia, ketoacidosis and subcutaneous or intravenous insulin infusions.
    MacRury SM; Small M; MacCuish AC
    Diabetes Res; 1987 Jul; 5(3):153-5. PubMed ID: 3117474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin.
    Freidenberg GR; White N; Cataland S; O'Dorisio TM; Sotos JF; Santiago JV
    N Engl J Med; 1981 Aug; 305(7):363-8. PubMed ID: 7019707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of adult inpatients treated with continuous subcutaneous insulin infusion for diabetes mellitus: a systematic review.
    Anstey J; Yassaee A; Solomon A
    Diabet Med; 2015 Oct; 32(10):1279-88. PubMed ID: 25763540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.